- Home
- LRHC vs KLTO Comparison
LRHC vs KLTO Comparison
Compare LRHC & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- KLTO
- Stock Information
- Founded
- LRHC 2004
- KLTO 2019
- Country
- LRHC United States
- KLTO United States
- Employees
- LRHC N/A
- KLTO N/A
- Industry
- LRHC
- KLTO
- Sector
- LRHC
- KLTO
- Exchange
- LRHC Nasdaq
- KLTO NYSE
- Market Cap
- LRHC 5.6M
- KLTO 5.9M
- IPO Year
- LRHC 2023
- KLTO N/A
- Fundamental
- Price
- LRHC $0.14
- KLTO $0.71
- Analyst Decision
- LRHC
- KLTO
- Analyst Count
- LRHC 0
- KLTO 0
- Target Price
- LRHC N/A
- KLTO N/A
- AVG Volume (30 Days)
- LRHC 4.1M
- KLTO 84.5M
- Earning Date
- LRHC 08-14-2025
- KLTO 08-15-2025
- Dividend Yield
- LRHC N/A
- KLTO N/A
- EPS Growth
- LRHC N/A
- KLTO N/A
- EPS
- LRHC N/A
- KLTO N/A
- Revenue
- LRHC $73,874,281.00
- KLTO N/A
- Revenue This Year
- LRHC N/A
- KLTO N/A
- Revenue Next Year
- LRHC N/A
- KLTO N/A
- P/E Ratio
- LRHC N/A
- KLTO N/A
- Revenue Growth
- LRHC 90.36
- KLTO N/A
- 52 Week Low
- LRHC $0.09
- KLTO $0.11
- 52 Week High
- LRHC $2.40
- KLTO $3.91
- Technical
- Relative Strength Index (RSI)
- LRHC 50.50
- KLTO N/A
- Support Level
- LRHC $0.12
- KLTO N/A
- Resistance Level
- LRHC $0.15
- KLTO N/A
- Average True Range (ATR)
- LRHC 0.01
- KLTO 0.00
- MACD
- LRHC 0.00
- KLTO 0.00
- Stochastic Oscillator
- LRHC 57.43
- KLTO 0.00
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.